SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000827871-16-000061
Filing Date
2016-05-09
Accepted
2016-05-09 07:12:54
Documents
3
Period of Report
2016-05-09
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K a8kmar2016cover-earnings.htm 8-K 22490
2 EXHIBIT 99.1 egrxq12016earningsrelease5.htm EX-99.1 120009
3 egrxq12016earningsrel_image1.gif GRAPHIC 7613
  Complete submission text file 0000827871-16-000061.txt   154313
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36306 | Film No.: 161629875
SIC: 2834 Pharmaceutical Preparations